SCHEMBL23969037

SCHEMBL23969037

N#CC(C#N)=C1c2cc(OC(F)(F)F)c(OC(F)(F)F)cc2-c2cc(OC(F)(F)F)c(OC(F)(F)F)cc21

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.37
ALDH1A1 P00352 2/20 0.37
PKM P14618 2/20 0.37
GAA P10253 1/20 0.37
EGFR P00533 2/20 0.34
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
TP53 P04637 1/20 0.32
CYP3A4 P08684 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
BLM P54132 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HIF1A Q16665 1/20 0.32
HSD17B10 Q99714 1/20 0.32
EPAS1 Q99814 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
HPRT1 P00492 1/20 0.31
PDE2A O00408 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12149348 0.98 MAPT (0.36) MAPTALDH1A1PKMGAAEGFR
SCHEMBL16433971 0.89 EGFR (0.32) MAPTALDH1A1PKMGAAEGFR
SCHEMBL21917087 0.89 KCNJ1 (0.34) MAPTALDH1A1PKMGAAEGFR
SCHEMBL21917670 0.89 KCNJ1 (0.34) MAPTALDH1A1PKMGAAEGFR
SCHEMBL23968934 0.89 CTSS (0.33) MAPTALDH1A1PKMGAAEGFR
SCHEMBL21917093 0.89 CTSS (0.33) MAPTALDH1A1PKMGAAEGFR
SCHEMBL20779037 0.88 EGFR (0.32) MAPTALDH1A1PKMGAAEGFR
SCHEMBL23968828 0.85 ALDH1A1 (0.31) MAPTALDH1A1PKMGAA
SCHEMBL21917313 0.83 BACE1 (0.37) MAPTALDH1A1PKMGAA
SCHEMBL20016052 0.82 MEN1 (0.30) MAPTALDH1A1MEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11165025-B2 Compound and organic electronic element comprising same LG CHEM, LTD. 2021-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11165025-B2 Compound and organic electronic element comprising same OR10J3, ESR1, ETV6 MAPT 1908/4885ALDH1A1 1094/4885PKM 2603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.